Presentation for your Synthetic Chemistry partner

1. A new Dimension to Chemistry

3. Our Vision Total Chemistry Solutions to enhance commercial value for healthcare customers

7. Bruker Avance III 400 MHz NMR with 120 sample auto-sampler 20 L Buchi Rotary Evaporator R-220 100 L Jacketed Reactor (-78 °C-+ 250°C) Agilent 1200 LC/MSD 2 L Paar Hydrogenator (Shaker System) Chemistry Solutions using Latest Equipment ISCO 16X Combiflash Companion System (3) 50 L Jacketed Glass Reactor (-78 °C- + 250° C) 1 liter Rotary Evaporator – (8) Chiral preparative HPLC system equipped with Varian’s SD 500ml/min pump system 5 L High Pressure Reactor (up to 300 PSI or 21 Kg) Huber Unistat 910w (-78 °C- + 250° C)

10. Kemxtree – Client Partnership Example of Project Flow Sign CDA (complete) Meet with client to discuss scope (complete) Proposal from Kemxtree & agreement to plan Sign Development Agreement Stage I: Literature Search (if needed) Stage 2: Plan and prioritize synthetic schemes with client Stage 3: Perform experiments and report results Stage 4: Final Report And Product Delivery Stage 5: Client Feedback

11. Management Team Nirmal Mulye, Ph.D . - President and CEO NPLLC – Dr. Mulye is the founder of Nostrum Pharmaceuticals, a developer of pharmaceutical formulation and related proprietary technologies and has over 12 patents to his credit. He is an industry veteran with over 18 years of experience. He was previously employed by Forest Laboratories Prashant Rele Managing Director Nexgen Healthcare Pvt. Ltd. . Mr. Rele is the Managing Director of Nexgen, a pharmaceutical company based out of Mumbai, India. He has more than 20 years of experience in marketing Pharmaceuticals in several markets across the globe. Nexgen markets products in key global markets and has a business model to develop a network of strategic partnerships for delivering products and services. Rohinton (Ronnie) Toddywala, Ph.D. MBA – CEO Kemxtree, LLC - Dr. Toddywala currently serves as the CEO of Nostrum Technologies,LLC and Kemxtree LLC. He has 19+ years' experience in the pharmaceutical, consumer and medical device industry including several key scientific and management positions at Colgate Palmolive Company and Johnson & Johnson. He also serves on the board of Merlin MD a medical device company and Symmetrix Biotech Pte. Ltd both companies based in Singapore. Nalinkant Rathod – Gimbal Capital - Mr Rathod is President Director of PT Bakrie & Brothers Tbk since March, 2008 the holding company for the Bakrie Group which is one of the largest conglomerates in Indonesia with interests in Coal Mining, Telecommunication and Infrastructure Sectors. Mr. Rathod is an investor in Symmtrix Biotech. Pte. Ltd. through Gimbal Capital.

14. We invite you to partner with us ! THANK YOU